Your browser doesn't support javascript.
loading
A phase 3, multicenter, randomized, double-blind, active-comparator-controlled study to evaluate the safety, tolerability, and immunogenicity of a 4-dose regimen of V114, a 15-valent pneumococcal conjugate vaccine, in healthy infants (PNEU-PED).
Lupinacci, Robert; Rupp, Richard; Wittawatmongkol, Orasri; Jones, Jake; Quinones, Jeffrey; Ulukol, Betul; Dagan, Ron; Richmond, Peter; Stek, Jon E; Romero, Lizbeth; Koseoglu, Sandra; Tamms, Gretchen; McFetridge, Richard; Li, Jianing; Cheon, Kyeongmi; Musey, Luwy; Banniettis, Natalie; Bickham, Kara.
  • Lupinacci R; Merck & Co., Inc., Rahway, NJ, USA. Electronic address: robert_lupinacci@merck.com.
  • Rupp R; University of Texas Medical Branch, Galveston, TX, USA.
  • Wittawatmongkol O; Mahidol University, Bangkok, Thailand.
  • Jones J; Wasatch Pediatrics, Murray, UT, USA.
  • Quinones J; Clinical Research of Puerto Rico, Guayama, Puerto Rico, USA.
  • Ulukol B; Ankara University, Ankara, Turkey.
  • Dagan R; The Shraga Segal Department of Microbiology, Immunology, and Genetics, Faculty of Health Sciences of the Ben-Gurion University of the Negev, Beer-Sheva, Israel.
  • Richmond P; University of Western Australia School of Medicine, Perth, Australia.
  • Stek JE; Merck & Co., Inc., Rahway, NJ, USA.
  • Romero L; Merck & Co., Inc., Rahway, NJ, USA.
  • Koseoglu S; Merck & Co., Inc., Rahway, NJ, USA.
  • Tamms G; Merck & Co., Inc., Rahway, NJ, USA.
  • McFetridge R; Merck & Co., Inc., Rahway, NJ, USA.
  • Li J; Merck & Co., Inc., Rahway, NJ, USA.
  • Cheon K; Merck & Co., Inc., Rahway, NJ, USA.
  • Musey L; Merck & Co., Inc., Rahway, NJ, USA.
  • Banniettis N; Merck & Co., Inc., Rahway, NJ, USA.
  • Bickham K; Merck & Co., Inc., Rahway, NJ, USA.
Vaccine ; 41(5): 1142-1152, 2023 01 27.
Article en En | MEDLINE | ID: mdl-36621410
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Infecciones Neumocócicas / Anticuerpos Antibacterianos Tipo de estudio: Clinical_trials Límite: Child / Humans / Infant Idioma: En Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Infecciones Neumocócicas / Anticuerpos Antibacterianos Tipo de estudio: Clinical_trials Límite: Child / Humans / Infant Idioma: En Año: 2023 Tipo del documento: Article